Google’s DeepMind beat 99.8% of humans at StarCraft II, but bigger challenge was not giving itself away.
AI becomes grandmaster in ‘fiendishly complex’ StarCraft II.
This is yet another glaring example of the innovative spirit of Silicon Valley. The startup has been successfully testing the novel idea on its El Camino Real spacecraft — launched on a Russian Soyuz rocket in July 2019. Momentus will continue to perform simulations on its spacecraft for the next few months to gather enough data to compare it with the results of the ground tests to validate the proper functioning of the new system.
It’s spacecraft, El Camino Real, is a 16-unit CubeSat integrated by Astro Digital — a spacecraft manufacturer and geospatial data analysis company based out of California as well. Momentus has already secured funding of $34 million funding to develop two shuttles, Vigoride and Vigoride Extended, which will maneuver satellites between orbits.
The most prominent application for this is when new satellites are deployed in orbits via rockets. When the former is dropped off in orbits, they can be moved to optimal positions using this technology in a cheap & efficient manner. Momentus originally started off in 2018 as a transportation service for small satellites seeking rides to medium Earth, geostationary or low lunar orbit.
After reading the new book “The Case Against Reality: Why evolution hid the truth from our eyes” by cognitive scientist Donald D. Hoffman, many academics and general readers alike may conclude that the Interface Theory of Perception well might be regarded as the most advanced theory of consciousness to date. If you dare to glance outside the paradigmatic square of neuroscience and neurophilosophy, then this book opens up a brand new perspective shedding light on the most probable future venue of scientific endeavor for the theory of everything with computational underpinnings and revolving around phenomenal consciousness.
Challenging the orthodoxy of still-predominant physicalism with undeniable logic and recent epistemological discoveries, Donald Hoffman crafts out his new Interface Theory of Perception which, for some inexplicable reason has been overlooked for so long and is but self-evident: Each conscious agent inhabits their own virtual bubble-universe while using species-specific sensory-cognitive modality in interfacing with objective reality.
In my recently-published book The Syntellect Hypothesis: Five Paradigms of the Mind’s Evolution (2019) I go a step further by submitting to you that “that something in objective reality” (in the words of Hoffman) is nothing less than non-local consciousness, or the Universal Mind if you prefer, co-creating each and every observer timeline. My ‘Experiential Realism’ is Hoffman’s Conscious Realism.
Different measurements of the universe’s expansion yield different results. Are we getting something wrong, or do we need brand-new physics to figure it out?
The main component of the LUX-ZEPLIN dark-matter detector has been installed at the Sanford Underground Research Facility in Lead, South Dakota.
The central cryostat for the experiment, which weighs about 2200 kg, was successfully lowered some 1500 m underground last week. Over the coming months, the detector will be wrapped in layers of insulation and then next year be filled with around 10 tonnes of ultra-pure liquid xenon.
LUX-ZEPLIN is expected to begin operation in July 2020 when it will become the largest direct detection dark-matter experiment in the US. It will search for weakly interacting massive particles – a leading dark-matter candidate – with scientists hoping to capture flashes of light that are produced when dark-matter particles interact with the heavy xenon atoms.
Humans’ guts are a dangerous place.
Bacteria living in people’s intestines pump out toxins to deter microbial intruders. But each person’s gut comes with its own set of toxins—an individualized “passcode” microbes must solve to survive, scientists report October 30, 2019, in the journal Nature.
The findings suggest that there’s not a one-size-fits-all approach to probiotics or live biotherapeutics, the microbial supplements that promote the growth of healthy bacteria, says study coauthor Joseph Mougous, a Howard Hughes Medical Institute (HHMI) Investigator at the University of Washington (UW). His team’s work is an early step toward figuring out how scientists might instead tailor beneficial microbes to different people.
A brand-new particle has possibly emerged and is altering the future destiny of our entire cosmos, a physicist says.
At the University of Copenhagen, researchers have discovered how some types of proteins stabilize damaged DNA and thereby preserve DNA function and integrity. This new finding also explains why people with inborn or acquired defects in certain proteins cannot keep their DNA stable and develop diseases such as cancer.
Every day, the body’s cells divide millions of times, and the maintenance of their identity requires that a mother cell passes complete genetic information to daughter cells without mistakes.
This is not a small task because our DNA is constantly under attack, both from the environment but also from the cell’s own metabolic activities. As a result, DNA strands can be broken at least once during each cell division cycle and this frequency can increase by certain lifestyles, such as smoking, or in individuals who are born with defects in DNA repair.
Higher serum levels of elaidic acid, an objective biomarker for industrial trans fat, are associated with an increased risk for developing all-cause dementia and Alzheimer disease, according to a study published online Oct. 23 in Neurology.
Takanori Honda, Ph.D., from Kyushu University in Fukuoka, Japan, and colleagues examined the prospective correlation between serum elaidic acid (trans 18:1 n-9) levels and incident dementia in 1,628 Japanese community residents aged 60 years and older without dementia. Participants underwent screening examination in 2002 to 2003 and were followed prospectively to November 2012.
The researchers found that 377 participants developed some type of dementia during follow-up. After adjustment for traditional risk factors, significant correlations were seen for higher serum elaidic acid levels with greater risk for developing all-cause dementia and Alzheimer disease. After adjustment for dietary factors, including total energy intake and intakes of saturated and polyunsaturated fatty acids, these associations remained significant. There was no significant correlation noted for serum elaidic acid levels and vascular dementia.
